NCT07435051
Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis
StatusRecruiting
PhasePhase 3
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date changed from estimate of May 1, 2026 to Oct 26, 2026
- Eligibility criteria expanded, about 8 words
- Site details revised
- Notable Changed Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University to Second Affiliated Hospital, Zhejiang University, School of Medicine
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Infection control rate at 6 months
Timeframe: 6 months
Secondary (1)
Infection control rate within 1 year
Arms and interventions
Bisphosphonates Combined with VancomycinExperimental
To evaluate the infection control effect of bisphosphonate combined with vancomycin in treatment of refractory osteomyelitis.
VancomycinActive comparator
Effect of vancomycin on infection control of refractory osteomyelitis.
Drugs: Bisphosphonates Combined with Vancomycin, Vancomycin
Sites
1 site in 1 country
- the Second Affiliated Hospital of Zhejiang University School of MedicineHangzhou, Zhejiang, China